Influenza A And B Treatment And Prophylaxis Therapeutics
1. Tamiflu patent expiration
Treatment: Treatment and prophylaxis of influenza
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5952375 | ROCHE | Compounds and methods for synthesis and therapy |
Feb, 2015
(10 years ago) | |
| US5763483 | ROCHE | Carbocyclic compounds |
Dec, 2016
(9 years ago) | |
| US5866601 | ROCHE | Carbocyclic compounds |
Feb, 2016
(9 years ago) | |
|
US5952375 (Pediatric) | ROCHE | Compounds and methods for synthesis and therapy |
Aug, 2015
(10 years ago) | |
|
US5763483 (Pediatric) | ROCHE | Carbocyclic compounds |
Jun, 2017
(8 years ago) | |
|
US5866601 (Pediatric) | ROCHE | Carbocyclic compounds |
Aug, 2016
(9 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-90) | Feb 22, 2013 |
| New Patient Population(NPP) | Dec 21, 2015 |
| M(M-251) | Aug 02, 2022 |
Drugs and Companies using OSELTAMIVIR PHOSPHATE ingredient
Market Authorisation Date: 02 July, 2007
Dosage: CAPSULE; FOR SUSPENSION
How can I launch a generic of TAMIFLU before it's drug patent expiration?
More Information on Dosage
TAMIFLU family patents
